K. Akaya Smith

507 total citations
14 papers, 256 citations indexed

About

K. Akaya Smith is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Hepatology. According to data from OpenAlex, K. Akaya Smith has authored 14 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Cardiology and Cardiovascular Medicine and 3 papers in Hepatology. Recurrent topics in K. Akaya Smith's work include Pulmonary Hypertension Research and Treatments (13 papers), Cardiovascular Function and Risk Factors (6 papers) and Liver Disease and Transplantation (3 papers). K. Akaya Smith is often cited by papers focused on Pulmonary Hypertension Research and Treatments (13 papers), Cardiovascular Function and Risk Factors (6 papers) and Liver Disease and Transplantation (3 papers). K. Akaya Smith collaborates with scholars based in United States, United Kingdom and Switzerland. K. Akaya Smith's co-authors include Jason S. Fritz, Steven M. Kawut, Harold I. Palevsky, Christine Archer‐Chicko, Anjali Vaidya, Diane Pinder, Corey E. Ventetuolo, James R. Klinger, Vandana Khungar and Nicole B. Gabler and has published in prestigious journals such as Circulation, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

K. Akaya Smith

12 papers receiving 252 citations

Peers

K. Akaya Smith
Charlotte Berlier Switzerland
R Ewert Germany
Martha Kingman United States
Rachel Crackett United Kingdom
K. Akaya Smith
Citations per year, relative to K. Akaya Smith K. Akaya Smith (= 1×) peers Katarina Zeder

Countries citing papers authored by K. Akaya Smith

Since Specialization
Citations

This map shows the geographic impact of K. Akaya Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Akaya Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Akaya Smith more than expected).

Fields of papers citing papers by K. Akaya Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Akaya Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Akaya Smith. The network helps show where K. Akaya Smith may publish in the future.

Co-authorship network of co-authors of K. Akaya Smith

This figure shows the co-authorship network connecting the top 25 collaborators of K. Akaya Smith. A scholar is included among the top collaborators of K. Akaya Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Akaya Smith. K. Akaya Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Feng, Rui, Drew A. Torigian, Jason S. Fritz, et al.. (2024). Epicardial Adipose Tissue as an Independent Risk Factor for Mortality in Pulmonary Arterial Hypertension. CHEST Journal. 167(5). 1481–1492.
2.
Minhas, Jasleen, Jude Moutchia, Nadine Al‐Naamani, et al.. (2024). Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension. Annals of the American Thoracic Society. 21(6). 858–865. 1 indexed citations
3.
Matura, Lea Ann, Jamison D. Fargo, Kathleen Boyle, et al.. (2022). Symptom phenotypes in pulmonary arterial hypertension: The PAH “symptome”. Pulmonary Circulation. 12(3). e12135–e12135. 4 indexed citations
4.
McClelland, Robyn L., Dina Appleby, Jude Moutchia, et al.. (2022). BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension. CHEST Journal. 162(2). 436–447. 11 indexed citations
5.
Min, Jeff, Dina Appleby, Robyn L. McClelland, et al.. (2021). Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants. Annals of the American Thoracic Society. 19(6). 952–961. 15 indexed citations
6.
Chirinos, Julio A., Bonnie Ky, Jeremy A. Mazurek, et al.. (2021). Systemic arterial properties in pulmonary hypertension. Pulmonary Circulation. 11(4). 1–3.
8.
Smith, K. Akaya, et al.. (2017). Hepatopulmonary Syndrome and Portopulmonary Hypertension. Clinics in Chest Medicine. 38(4). 785–795. 21 indexed citations
9.
Kawut, Steven M., Christine Archer‐Chicko, Angela DeMichele, et al.. (2016). Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine. 195(3). 360–368. 82 indexed citations
10.
Matura, Lea Ann, Jamison D. Fargo, Jason S. Fritz, et al.. (2016). Slow-paced respiration therapy to treat symptoms in pulmonary arterial hypertension. Heart & Lung. 46(1). 7–13. 9 indexed citations
11.
Fritz, Jason S. & K. Akaya Smith. (2016). The Pulmonary Hypertension Consult. CHEST Journal. 150(3). 705–713. 6 indexed citations
12.
Matura, Lea Ann, Haochang Shou, Jason S. Fritz, et al.. (2016). Physical Activity and Symptoms in Pulmonary Arterial Hypertension. CHEST Journal. 150(1). 46–56. 44 indexed citations
13.
Ventetuolo, Corey E., Nicole B. Gabler, Jason S. Fritz, et al.. (2014). Are Hemodynamics Surrogate End Points in Pulmonary Arterial Hypertension?. Circulation. 130(9). 768–775. 44 indexed citations
14.
Rosenberg, Jack M., Joyce A. Wahr, & K. Akaya Smith. (1995). Effect of vancomycin infusion on cardiac function in patients scheduled for cardiac operation. Journal of Thoracic and Cardiovascular Surgery. 109(3). 561–564. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026